Kevzara 200 mg / 1.14 mL pre-filled pen Images
Generic Name: sarilumab
This medication has been identified as Kevzara 200 mg / 1.14 mL pre-filled pen. It is supplied by Regeneron Pharmaceuticals, Inc.
Kevzara is used in the treatment of Polymyalgia Rheumatica; Rheumatoid Arthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug classes antirheumatics, interleukin inhibitors. Kevzara 200 mg / 1.14 mL pre-filled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Kevzara
- Generic Name
- sarilumab
- Strength
- 200 mg / 1.14 mL pre-filled pen
- Availability
- Prescription only
- Drug Class
- Antirheumatics, Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- Manufacturer
- sanofi-aventis U.S. LLC
- National Drug Code (NDC)
- 00024-5922
More about Kevzara (sarilumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
